岡林 剛史

Medicine & Life Sciences

1. Colorectal Neoplasms 100%
2. Rectal Neoplasms 43%
3. Laparoscopy 42%
4. Colonic Neoplasms 38%
5. Surgical Wound Infection 34%
6. Neoplasm Metastasis 34%
7. Colorectal Surgery 31%
8. Recurrence 29%
9. Ulcerative Colitis 28%
10. Neoplasms 23%
11. Meta-Analysis 22%
12. olanexidine 20%
13. Colectomy 20%
14. Fluorouracil 20%
15. Japan 19%
16. Postoperative Complications 18%
17. HSP27 Heat-Shock Proteins 17%
18. Anastomotic Leak 17%
19. Crohn Disease 17%
20. Survival 15%
21. Leucovorin 14%
22. Lymph Nodes 14%
23. Systematic Reviews 14%
24. Tegafur 14%
25. Network Meta-Analysis 13%
26. Drug Therapy 13%
27. Hernia 13%
28. Esophageal Neoplasms 12%
29. Confidence Intervals 12%
30. Irinotecan 11%
31. Cetuximab 11%
32. Incidence 11%
33. Obesity 11%
34. Therapeutics 10%
35. Adjuvant Chemotherapy 10%
36. Survival Rate 10%
37. Liver 9%
38. Multivariate Analysis 9%
39. Intraabdominal Infections 9%
40. Antisepsis 9%
41. Povidone-Iodine 9%
42. ErbB Receptors 9%
43. Transverse Colon 9%
44. Randomized Controlled Trials 9%
45. Pouchitis 9%
46. Odds Ratio 9%
47. Uracil 8%
48. Drainage 8%
49. Intestinal Neoplasms 8%
50. Disease-Free Survival 7%